NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+11.66%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.41B
AUM Growth
+$204M
(+17%)
Cap. Flow
+$59.3M
Cap. Flow
% of AUM
4.19%
Top 10 Holdings %
Top 10 Hldgs %
37.13%
Holding
155
New
17
Increased
44
Reduced
11
Closed
8
Top Buys
| 1 |
Xtant Medical Holdings
XTNT
|
+$42.1M |
| 2 |
JCAP
Jefferson Capital, Inc. Common Stock
JCAP
|
+$11.1M |
| 3 |
TriSalus Life Sciences
TLSI
|
+$10.9M |
| 4 |
Jack in the Box
JACK
|
+$10.5M |
| 5 |
1-800-Flowers.com
FLWS
|
+$9.84M |
Top Sells
| 1 |
Soleno Therapeutics
SLNO
|
+$63.3M |
| 2 |
Gogo Inc
GOGO
|
+$37M |
| 3 |
UroGen Pharma
URGN
|
+$18.6M |
| 4 |
RH
RH
|
+$11.8M |
| 5 |
uniQure
QURE
|
+$9.82M |
Sector Composition
| 1 | Healthcare | 63.53% |
| 2 | Consumer Discretionary | 15.72% |
| 3 | Communication Services | 5.76% |
| 4 | Financials | 5.29% |
| 5 | Industrials | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
InspireMD
NSPR
$100M
| $5.26M | 0.21% |
2,318,017
| – | – |
|
77
NN Inc
NNBR
$126M
| $5.13M | 0.2% |
2,441,416
+1,000,000
| +69% | +$2.1M |
|
78
Avalo Therapeutics
AVTX
$150M
| $4.97M | 0.19% |
995,000
+95,000
| +11% | +$474K |
|
79
Mineralys Therapeutics
MLYS
$2.79B
| $4.79M | 0.19% |
353,982
-433,758
| -55% | -$5.87M |
|
80
Hain Celestial
HAIN
$168M
| $4.56M | 0.18% |
+3,000,000
| New | +$4.56M |
|
81
Unicycive Therapeutics
UNCY
$77.2M
| $4.56M | 0.18% |
939,202
+3
| +0% | +$15 |
|
|
CRGX
82
DELISTED
CARGO Therapeutics
CRGX
| $4.53M | 0.18% |
1,100,000
| – | – |
|
83
Anebulo Pharmaceuticals
ANEB
$90.4M
| $4.37M | 0.17% |
3,036,325
| – | – |
|
84
Inhibikase Therapeutics
IKT
$124M
| $4.27M | 0.17% |
2,190,000
| – | – |
|
85
Quince Therapeutics
QNCX
$84.3M
| $4.17M | 0.16% |
+2,528,302
| New | +$4.17M |
|
86
Gaia
GAIA
$140M
| $4.02M | 0.16% |
914,618
| – | – |
|
87
VistaGen Therapeutics
VTGN
$107M
| $3.96M | 0.16% |
1,978,492
| – | – |
|
88
scPharmaceuticals
SCPH
$300M
| $3.79M | 0.15% |
995,438
| – | – |
|
|
VERV
89
DELISTED
Verve Therapeutics
VERV
| $3.72M | 0.15% |
+331,437
| New | +$3.72M |
|
|
GRCE
90
Grace Therapeutics, Inc. Common Stock
GRCE
$44.8M
| $3.5M | 0.14% |
1,178,203
| – | – |
|
91
Structure Therapeutics
GPCR
$1.2B
| $3.5M | 0.14% |
168,553
| – | – |
|
92
Payoneer
PAYO
$2.44B
| $3.31M | 0.13% |
483,836
+335,784
| +227% | +$2.3M |
|
93
Neuropace
NPCE
$321M
| $3.29M | 0.13% |
295,089
-17,005
| -5% | -$189K |
|
94
Noodles & Co
NDLS
$30.9M
| $3.21M | 0.13% |
4,505,489
| – | – |
|
|
IRD
95
Opus Genetics, Inc. Common Stock
IRD
$83.9M
| $3.15M | 0.12% |
3,345,923
+188,028
| +6% | +$177K |
|
96
Columbus McKinnon
CMCO
$428M
| $3.11M | 0.12% |
203,628
+3,628
| +2% | +$55.4K |
|
97
Eledon Pharmaceuticals
ELDN
$154M
| $3.09M | 0.12% |
1,141,237
| – | – |
|
98
Kosmos Energy
KOS
$789M
| $2.95M | 0.12% |
1,716,593
| – | – |
|
99
Destination XL Group
DXLG
$67.9M
| $2.86M | 0.11% |
+2,576,774
| New | +$2.86M |
|
100
Caesars Entertainment
CZR
$5.49B
| $2.81M | 0.11% |
98,879
| – | – |
|